Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 7,679 | 7,190 | 7,338 | 6,081 | 10,380 |
Cost of Goods | 756 | 887 | 455 | 386 | 206 |
Gross Profit | 6,923 | 6,303 | 6,883 | 5,695 | 10,174 |
Operating Expenses | 43,500 | 42,627 | 38,984 | 37,520 | 43,343 |
Operating Income | -35,821 | -35,437 | -31,646 | -31,439 | -32,963 |
Interest Expense | 4,346 | 4,298 | 4,242 | 4,208 | 4,147 |
Other Income | 1,498 | -2,034 | 2,916 | 2,175 | 2,380 |
Pre-tax Income | -38,669 | -41,769 | -32,972 | -33,472 | -34,730 |
Income Tax | N/A | N/A | N/A | -1,538 | N/A |
Net Income Continuous | -38,669 | -41,769 | -32,972 | -31,934 | -34,730 |
Net Income | $-38,669 | $-41,769 | $-32,972 | $-31,934 | $-34,730 |
EPS Basic Total Ops | -0.68 | -0.74 | -0.61 | -0.61 | -0.67 |
EPS Basic Continuous Ops | -0.68 | -0.74 | -0.61 | -0.61 | -0.67 |
EPS Diluted Total Ops | -0.68 | -0.74 | -0.61 | -0.61 | -0.67 |
EPS Diluted Continuous Ops | -0.68 | -0.74 | -0.61 | -0.61 | -0.67 |
EPS Diluted Before Non-Recurring Items | N/A | -0.74 | -0.61 | -0.61 | -0.67 |
EBITDA(a) | $-35,567 | $-35,063 | $-31,695 | $-31,555 | $-32,967 |